nodes	percent_of_prediction	percent_of_DWPC	metapath
Bortezomib—CYP1A1—Omeprazole—Barrett's esophagus	0.132	0.211	CbGbCtD
Bortezomib—CYP2C19—Esomeprazole—Barrett's esophagus	0.108	0.174	CbGbCtD
Bortezomib—CYP2C8—Omeprazole—Barrett's esophagus	0.0762	0.122	CbGbCtD
Bortezomib—CYP2C19—Omeprazole—Barrett's esophagus	0.0639	0.102	CbGbCtD
Bortezomib—CYP1A2—Omeprazole—Barrett's esophagus	0.059	0.0944	CbGbCtD
Bortezomib—CYP2C9—Omeprazole—Barrett's esophagus	0.0531	0.085	CbGbCtD
Bortezomib—CYP3A4—Esomeprazole—Barrett's esophagus	0.0524	0.0839	CbGbCtD
Bortezomib—CYP2D6—Omeprazole—Barrett's esophagus	0.0486	0.0778	CbGbCtD
Bortezomib—CYP3A4—Omeprazole—Barrett's esophagus	0.0309	0.0494	CbGbCtD
Bortezomib—PSMA1—epithelium—Barrett's esophagus	0.00685	0.124	CbGeAlD
Bortezomib—PSMD1—smooth muscle tissue—Barrett's esophagus	0.00554	0.1	CbGeAlD
Bortezomib—PSMA1—digestive system—Barrett's esophagus	0.00521	0.0945	CbGeAlD
Bortezomib—PSMD2—smooth muscle tissue—Barrett's esophagus	0.00491	0.089	CbGeAlD
Bortezomib—PSMB5—smooth muscle tissue—Barrett's esophagus	0.00431	0.0781	CbGeAlD
Bortezomib—PSMD2—digestive system—Barrett's esophagus	0.00388	0.0702	CbGeAlD
Bortezomib—PSMB1—smooth muscle tissue—Barrett's esophagus	0.00377	0.0683	CbGeAlD
Bortezomib—PSMB2—smooth muscle tissue—Barrett's esophagus	0.00368	0.0666	CbGeAlD
Bortezomib—PSMB1—digestive system—Barrett's esophagus	0.00297	0.0539	CbGeAlD
Bortezomib—PSMB2—digestive system—Barrett's esophagus	0.0029	0.0526	CbGeAlD
Bortezomib—SLC31A1—digestive system—Barrett's esophagus	0.00251	0.0455	CbGeAlD
Bortezomib—Nateglinide—PPARG—Barrett's esophagus	0.00166	1	CrCbGaD
Bortezomib—CYP1A1—epithelium—Barrett's esophagus	0.00112	0.0203	CbGeAlD
Bortezomib—CYP2C19—digestive system—Barrett's esophagus	0.00106	0.0192	CbGeAlD
Bortezomib—PTGS1—epithelium—Barrett's esophagus	0.000986	0.0179	CbGeAlD
Bortezomib—PTGS1—smooth muscle tissue—Barrett's esophagus	0.00095	0.0172	CbGeAlD
Bortezomib—CYP1A2—digestive system—Barrett's esophagus	0.000865	0.0157	CbGeAlD
Bortezomib—CYP1A1—digestive system—Barrett's esophagus	0.000854	0.0155	CbGeAlD
Bortezomib—CYP2C9—digestive system—Barrett's esophagus	0.000821	0.0149	CbGeAlD
Bortezomib—PTGS1—digestive system—Barrett's esophagus	0.00075	0.0136	CbGeAlD
Bortezomib—Gastroenteritis—Esomeprazole—Barrett's esophagus	0.000704	0.0029	CcSEcCtD
Bortezomib—Gastroenteritis—Omeprazole—Barrett's esophagus	0.000704	0.0029	CcSEcCtD
Bortezomib—Vascular purpura—Omeprazole—Barrett's esophagus	0.000697	0.00288	CcSEcCtD
Bortezomib—Vascular purpura—Esomeprazole—Barrett's esophagus	0.000697	0.00288	CcSEcCtD
Bortezomib—Hepatic failure—Esomeprazole—Barrett's esophagus	0.000694	0.00286	CcSEcCtD
Bortezomib—Hepatic failure—Omeprazole—Barrett's esophagus	0.000694	0.00286	CcSEcCtD
Bortezomib—Haemolytic anaemia—Esomeprazole—Barrett's esophagus	0.000691	0.00285	CcSEcCtD
Bortezomib—Haemolytic anaemia—Omeprazole—Barrett's esophagus	0.000691	0.00285	CcSEcCtD
Bortezomib—Increased appetite—Esomeprazole—Barrett's esophagus	0.000664	0.00274	CcSEcCtD
Bortezomib—Increased appetite—Omeprazole—Barrett's esophagus	0.000664	0.00274	CcSEcCtD
Bortezomib—Thirst—Esomeprazole—Barrett's esophagus	0.000655	0.0027	CcSEcCtD
Bortezomib—Thirst—Omeprazole—Barrett's esophagus	0.000655	0.0027	CcSEcCtD
Bortezomib—Renal impairment—Omeprazole—Barrett's esophagus	0.000655	0.0027	CcSEcCtD
Bortezomib—Renal impairment—Esomeprazole—Barrett's esophagus	0.000655	0.0027	CcSEcCtD
Bortezomib—Purpura—Esomeprazole—Barrett's esophagus	0.000647	0.00267	CcSEcCtD
Bortezomib—Purpura—Omeprazole—Barrett's esophagus	0.000647	0.00267	CcSEcCtD
Bortezomib—Arthritis—Esomeprazole—Barrett's esophagus	0.000642	0.00265	CcSEcCtD
Bortezomib—Arthritis—Omeprazole—Barrett's esophagus	0.000642	0.00265	CcSEcCtD
Bortezomib—CYP3A4—digestive system—Barrett's esophagus	0.000626	0.0114	CbGeAlD
Bortezomib—Hyponatraemia—Esomeprazole—Barrett's esophagus	0.000626	0.00258	CcSEcCtD
Bortezomib—Hyponatraemia—Omeprazole—Barrett's esophagus	0.000626	0.00258	CcSEcCtD
Bortezomib—Pain in extremity—Esomeprazole—Barrett's esophagus	0.000624	0.00257	CcSEcCtD
Bortezomib—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	0.000624	0.00257	CcSEcCtD
Bortezomib—Osteoarthritis—Omeprazole—Barrett's esophagus	0.000624	0.00257	CcSEcCtD
Bortezomib—Diplopia—Omeprazole—Barrett's esophagus	0.000624	0.00257	CcSEcCtD
Bortezomib—Gastrointestinal haemorrhage—Omeprazole—Barrett's esophagus	0.000624	0.00257	CcSEcCtD
Bortezomib—Diplopia—Esomeprazole—Barrett's esophagus	0.000624	0.00257	CcSEcCtD
Bortezomib—Pain in extremity—Omeprazole—Barrett's esophagus	0.000624	0.00257	CcSEcCtD
Bortezomib—Osteoarthritis—Esomeprazole—Barrett's esophagus	0.000624	0.00257	CcSEcCtD
Bortezomib—CYP2D6—digestive system—Barrett's esophagus	0.000616	0.0112	CbGeAlD
Bortezomib—Migraine—Esomeprazole—Barrett's esophagus	0.000614	0.00253	CcSEcCtD
Bortezomib—Migraine—Omeprazole—Barrett's esophagus	0.000614	0.00253	CcSEcCtD
Bortezomib—Face oedema—Esomeprazole—Barrett's esophagus	0.000602	0.00248	CcSEcCtD
Bortezomib—Face oedema—Omeprazole—Barrett's esophagus	0.000602	0.00248	CcSEcCtD
Bortezomib—Irritability—Omeprazole—Barrett's esophagus	0.000595	0.00245	CcSEcCtD
Bortezomib—Irritability—Esomeprazole—Barrett's esophagus	0.000595	0.00245	CcSEcCtD
Bortezomib—Dry skin—Omeprazole—Barrett's esophagus	0.000572	0.00236	CcSEcCtD
Bortezomib—Dry skin—Esomeprazole—Barrett's esophagus	0.000572	0.00236	CcSEcCtD
Bortezomib—Abdominal pain upper—Esomeprazole—Barrett's esophagus	0.00057	0.00235	CcSEcCtD
Bortezomib—Abdominal pain upper—Omeprazole—Barrett's esophagus	0.00057	0.00235	CcSEcCtD
Bortezomib—Hypokalaemia—Omeprazole—Barrett's esophagus	0.000568	0.00234	CcSEcCtD
Bortezomib—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.000568	0.00234	CcSEcCtD
Bortezomib—Breast disorder—Omeprazole—Barrett's esophagus	0.000564	0.00232	CcSEcCtD
Bortezomib—Breast disorder—Esomeprazole—Barrett's esophagus	0.000564	0.00232	CcSEcCtD
Bortezomib—Cramp muscle—Esomeprazole—Barrett's esophagus	0.000562	0.00232	CcSEcCtD
Bortezomib—Toxic epidermal necrolysis—Esomeprazole—Barrett's esophagus	0.000562	0.00232	CcSEcCtD
Bortezomib—Cramp muscle—Omeprazole—Barrett's esophagus	0.000562	0.00232	CcSEcCtD
Bortezomib—Toxic epidermal necrolysis—Omeprazole—Barrett's esophagus	0.000562	0.00232	CcSEcCtD
Bortezomib—Gastritis—Omeprazole—Barrett's esophagus	0.000552	0.00228	CcSEcCtD
Bortezomib—Gastritis—Esomeprazole—Barrett's esophagus	0.000552	0.00228	CcSEcCtD
Bortezomib—Muscular weakness—Esomeprazole—Barrett's esophagus	0.00055	0.00227	CcSEcCtD
Bortezomib—Muscular weakness—Omeprazole—Barrett's esophagus	0.00055	0.00227	CcSEcCtD
Bortezomib—Abdominal distension—Omeprazole—Barrett's esophagus	0.000543	0.00224	CcSEcCtD
Bortezomib—Abdominal distension—Esomeprazole—Barrett's esophagus	0.000543	0.00224	CcSEcCtD
Bortezomib—Dysphagia—Esomeprazole—Barrett's esophagus	0.000539	0.00222	CcSEcCtD
Bortezomib—Influenza—Esomeprazole—Barrett's esophagus	0.000539	0.00222	CcSEcCtD
Bortezomib—Dysphagia—Omeprazole—Barrett's esophagus	0.000539	0.00222	CcSEcCtD
Bortezomib—Influenza—Omeprazole—Barrett's esophagus	0.000539	0.00222	CcSEcCtD
Bortezomib—Bronchospasm—Esomeprazole—Barrett's esophagus	0.00053	0.00219	CcSEcCtD
Bortezomib—Bronchospasm—Omeprazole—Barrett's esophagus	0.00053	0.00219	CcSEcCtD
Bortezomib—Pancreatitis—Esomeprazole—Barrett's esophagus	0.000528	0.00218	CcSEcCtD
Bortezomib—Pancreatitis—Omeprazole—Barrett's esophagus	0.000528	0.00218	CcSEcCtD
Bortezomib—Angina pectoris—Omeprazole—Barrett's esophagus	0.000525	0.00217	CcSEcCtD
Bortezomib—Angina pectoris—Esomeprazole—Barrett's esophagus	0.000525	0.00217	CcSEcCtD
Bortezomib—Pancytopenia—Omeprazole—Barrett's esophagus	0.000512	0.00211	CcSEcCtD
Bortezomib—Pancytopenia—Esomeprazole—Barrett's esophagus	0.000512	0.00211	CcSEcCtD
Bortezomib—Neutropenia—Omeprazole—Barrett's esophagus	0.000504	0.00208	CcSEcCtD
Bortezomib—Neutropenia—Esomeprazole—Barrett's esophagus	0.000504	0.00208	CcSEcCtD
Bortezomib—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.000501	0.00207	CcSEcCtD
Bortezomib—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.000501	0.00207	CcSEcCtD
Bortezomib—Pollakiuria—Omeprazole—Barrett's esophagus	0.000498	0.00205	CcSEcCtD
Bortezomib—Pollakiuria—Esomeprazole—Barrett's esophagus	0.000498	0.00205	CcSEcCtD
Bortezomib—Erectile dysfunction—Omeprazole—Barrett's esophagus	0.000496	0.00205	CcSEcCtD
Bortezomib—Erectile dysfunction—Esomeprazole—Barrett's esophagus	0.000496	0.00205	CcSEcCtD
Bortezomib—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.000492	0.00203	CcSEcCtD
Bortezomib—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.000492	0.00203	CcSEcCtD
Bortezomib—Weight increased—Esomeprazole—Barrett's esophagus	0.000491	0.00202	CcSEcCtD
Bortezomib—Weight increased—Omeprazole—Barrett's esophagus	0.000491	0.00202	CcSEcCtD
Bortezomib—Weight decreased—Omeprazole—Barrett's esophagus	0.000488	0.00201	CcSEcCtD
Bortezomib—Weight decreased—Esomeprazole—Barrett's esophagus	0.000488	0.00201	CcSEcCtD
Bortezomib—Infestation NOS—Omeprazole—Barrett's esophagus	0.000481	0.00198	CcSEcCtD
Bortezomib—Infestation—Omeprazole—Barrett's esophagus	0.000481	0.00198	CcSEcCtD
Bortezomib—Infestation NOS—Esomeprazole—Barrett's esophagus	0.000481	0.00198	CcSEcCtD
Bortezomib—Infestation—Esomeprazole—Barrett's esophagus	0.000481	0.00198	CcSEcCtD
Bortezomib—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.000477	0.00197	CcSEcCtD
Bortezomib—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.000477	0.00197	CcSEcCtD
Bortezomib—Renal failure—Esomeprazole—Barrett's esophagus	0.000472	0.00195	CcSEcCtD
Bortezomib—Renal failure—Omeprazole—Barrett's esophagus	0.000472	0.00195	CcSEcCtD
Bortezomib—Stomatitis—Omeprazole—Barrett's esophagus	0.000468	0.00193	CcSEcCtD
Bortezomib—Stomatitis—Esomeprazole—Barrett's esophagus	0.000468	0.00193	CcSEcCtD
Bortezomib—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.000467	0.00193	CcSEcCtD
Bortezomib—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.000467	0.00193	CcSEcCtD
Bortezomib—Urinary tract infection—Omeprazole—Barrett's esophagus	0.000467	0.00193	CcSEcCtD
Bortezomib—Conjunctivitis—Omeprazole—Barrett's esophagus	0.000467	0.00193	CcSEcCtD
Bortezomib—Haematuria—Omeprazole—Barrett's esophagus	0.000458	0.00189	CcSEcCtD
Bortezomib—Haematuria—Esomeprazole—Barrett's esophagus	0.000458	0.00189	CcSEcCtD
Bortezomib—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.000455	0.00187	CcSEcCtD
Bortezomib—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.000455	0.00187	CcSEcCtD
Bortezomib—Epistaxis—Esomeprazole—Barrett's esophagus	0.000453	0.00187	CcSEcCtD
Bortezomib—Epistaxis—Omeprazole—Barrett's esophagus	0.000453	0.00187	CcSEcCtD
Bortezomib—Sinusitis—Omeprazole—Barrett's esophagus	0.000451	0.00186	CcSEcCtD
Bortezomib—Sinusitis—Esomeprazole—Barrett's esophagus	0.000451	0.00186	CcSEcCtD
Bortezomib—Bradycardia—Omeprazole—Barrett's esophagus	0.000439	0.00181	CcSEcCtD
Bortezomib—Bradycardia—Esomeprazole—Barrett's esophagus	0.000439	0.00181	CcSEcCtD
Bortezomib—Hepatitis—Esomeprazole—Barrett's esophagus	0.000431	0.00178	CcSEcCtD
Bortezomib—Hepatitis—Omeprazole—Barrett's esophagus	0.000431	0.00178	CcSEcCtD
Bortezomib—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.000429	0.00177	CcSEcCtD
Bortezomib—Hallucination—Omeprazole—Barrett's esophagus	0.000429	0.00177	CcSEcCtD
Bortezomib—Hallucination—Esomeprazole—Barrett's esophagus	0.000429	0.00177	CcSEcCtD
Bortezomib—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.000429	0.00177	CcSEcCtD
Bortezomib—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.000426	0.00176	CcSEcCtD
Bortezomib—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.000426	0.00176	CcSEcCtD
Bortezomib—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.000425	0.00175	CcSEcCtD
Bortezomib—Oedema peripheral—Omeprazole—Barrett's esophagus	0.000425	0.00175	CcSEcCtD
Bortezomib—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.000424	0.00175	CcSEcCtD
Bortezomib—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.000424	0.00175	CcSEcCtD
Bortezomib—Urethral disorder—Esomeprazole—Barrett's esophagus	0.000423	0.00174	CcSEcCtD
Bortezomib—Urethral disorder—Omeprazole—Barrett's esophagus	0.000423	0.00174	CcSEcCtD
Bortezomib—Visual impairment—Omeprazole—Barrett's esophagus	0.000416	0.00171	CcSEcCtD
Bortezomib—Visual impairment—Esomeprazole—Barrett's esophagus	0.000416	0.00171	CcSEcCtD
Bortezomib—Erythema multiforme—Omeprazole—Barrett's esophagus	0.000408	0.00168	CcSEcCtD
Bortezomib—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.000408	0.00168	CcSEcCtD
Bortezomib—Eye disorder—Omeprazole—Barrett's esophagus	0.000403	0.00166	CcSEcCtD
Bortezomib—Eye disorder—Esomeprazole—Barrett's esophagus	0.000403	0.00166	CcSEcCtD
Bortezomib—Tinnitus—Omeprazole—Barrett's esophagus	0.000402	0.00166	CcSEcCtD
Bortezomib—Tinnitus—Esomeprazole—Barrett's esophagus	0.000402	0.00166	CcSEcCtD
Bortezomib—Flushing—Esomeprazole—Barrett's esophagus	0.0004	0.00165	CcSEcCtD
Bortezomib—Flushing—Omeprazole—Barrett's esophagus	0.0004	0.00165	CcSEcCtD
Bortezomib—Immune system disorder—Omeprazole—Barrett's esophagus	0.00039	0.00161	CcSEcCtD
Bortezomib—Immune system disorder—Esomeprazole—Barrett's esophagus	0.00039	0.00161	CcSEcCtD
Bortezomib—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.000389	0.0016	CcSEcCtD
Bortezomib—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.000389	0.0016	CcSEcCtD
Bortezomib—Chills—Esomeprazole—Barrett's esophagus	0.000387	0.0016	CcSEcCtD
Bortezomib—Chills—Omeprazole—Barrett's esophagus	0.000387	0.0016	CcSEcCtD
Bortezomib—Mental disorder—Esomeprazole—Barrett's esophagus	0.000378	0.00156	CcSEcCtD
Bortezomib—Mental disorder—Omeprazole—Barrett's esophagus	0.000378	0.00156	CcSEcCtD
Bortezomib—Malnutrition—Omeprazole—Barrett's esophagus	0.000376	0.00155	CcSEcCtD
Bortezomib—Malnutrition—Esomeprazole—Barrett's esophagus	0.000376	0.00155	CcSEcCtD
Bortezomib—Flatulence—Esomeprazole—Barrett's esophagus	0.00037	0.00153	CcSEcCtD
Bortezomib—Flatulence—Omeprazole—Barrett's esophagus	0.00037	0.00153	CcSEcCtD
Bortezomib—Dysgeusia—Omeprazole—Barrett's esophagus	0.000368	0.00152	CcSEcCtD
Bortezomib—Dysgeusia—Esomeprazole—Barrett's esophagus	0.000368	0.00152	CcSEcCtD
Bortezomib—Back pain—Omeprazole—Barrett's esophagus	0.000363	0.0015	CcSEcCtD
Bortezomib—Back pain—Esomeprazole—Barrett's esophagus	0.000363	0.0015	CcSEcCtD
Bortezomib—Muscle spasms—Omeprazole—Barrett's esophagus	0.000361	0.00149	CcSEcCtD
Bortezomib—Muscle spasms—Esomeprazole—Barrett's esophagus	0.000361	0.00149	CcSEcCtD
Bortezomib—Vision blurred—Esomeprazole—Barrett's esophagus	0.000354	0.00146	CcSEcCtD
Bortezomib—Vision blurred—Omeprazole—Barrett's esophagus	0.000354	0.00146	CcSEcCtD
Bortezomib—Tremor—Esomeprazole—Barrett's esophagus	0.000352	0.00145	CcSEcCtD
Bortezomib—Tremor—Omeprazole—Barrett's esophagus	0.000352	0.00145	CcSEcCtD
Bortezomib—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.000348	0.00144	CcSEcCtD
Bortezomib—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.000348	0.00144	CcSEcCtD
Bortezomib—Anaemia—Esomeprazole—Barrett's esophagus	0.000347	0.00143	CcSEcCtD
Bortezomib—Anaemia—Omeprazole—Barrett's esophagus	0.000347	0.00143	CcSEcCtD
Bortezomib—Agitation—Omeprazole—Barrett's esophagus	0.000345	0.00142	CcSEcCtD
Bortezomib—Agitation—Esomeprazole—Barrett's esophagus	0.000345	0.00142	CcSEcCtD
Bortezomib—Angioedema—Omeprazole—Barrett's esophagus	0.000343	0.00142	CcSEcCtD
Bortezomib—Angioedema—Esomeprazole—Barrett's esophagus	0.000343	0.00142	CcSEcCtD
Bortezomib—Malaise—Esomeprazole—Barrett's esophagus	0.000339	0.0014	CcSEcCtD
Bortezomib—Malaise—Omeprazole—Barrett's esophagus	0.000339	0.0014	CcSEcCtD
Bortezomib—Vertigo—Omeprazole—Barrett's esophagus	0.000337	0.00139	CcSEcCtD
Bortezomib—Vertigo—Esomeprazole—Barrett's esophagus	0.000337	0.00139	CcSEcCtD
Bortezomib—Leukopenia—Omeprazole—Barrett's esophagus	0.000336	0.00139	CcSEcCtD
Bortezomib—Leukopenia—Esomeprazole—Barrett's esophagus	0.000336	0.00139	CcSEcCtD
Bortezomib—Palpitations—Omeprazole—Barrett's esophagus	0.000332	0.00137	CcSEcCtD
Bortezomib—Palpitations—Esomeprazole—Barrett's esophagus	0.000332	0.00137	CcSEcCtD
Bortezomib—Cough—Omeprazole—Barrett's esophagus	0.000328	0.00135	CcSEcCtD
Bortezomib—Cough—Esomeprazole—Barrett's esophagus	0.000328	0.00135	CcSEcCtD
Bortezomib—Hypertension—Omeprazole—Barrett's esophagus	0.000324	0.00134	CcSEcCtD
Bortezomib—Hypertension—Esomeprazole—Barrett's esophagus	0.000324	0.00134	CcSEcCtD
Bortezomib—Myalgia—Esomeprazole—Barrett's esophagus	0.00032	0.00132	CcSEcCtD
Bortezomib—Arthralgia—Omeprazole—Barrett's esophagus	0.00032	0.00132	CcSEcCtD
Bortezomib—Chest pain—Omeprazole—Barrett's esophagus	0.00032	0.00132	CcSEcCtD
Bortezomib—Chest pain—Esomeprazole—Barrett's esophagus	0.00032	0.00132	CcSEcCtD
Bortezomib—Myalgia—Omeprazole—Barrett's esophagus	0.00032	0.00132	CcSEcCtD
Bortezomib—Arthralgia—Esomeprazole—Barrett's esophagus	0.00032	0.00132	CcSEcCtD
Bortezomib—Anxiety—Omeprazole—Barrett's esophagus	0.000319	0.00131	CcSEcCtD
Bortezomib—Anxiety—Esomeprazole—Barrett's esophagus	0.000319	0.00131	CcSEcCtD
Bortezomib—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.000318	0.00131	CcSEcCtD
Bortezomib—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.000318	0.00131	CcSEcCtD
Bortezomib—Discomfort—Esomeprazole—Barrett's esophagus	0.000316	0.0013	CcSEcCtD
Bortezomib—Discomfort—Omeprazole—Barrett's esophagus	0.000316	0.0013	CcSEcCtD
Bortezomib—Confusional state—Esomeprazole—Barrett's esophagus	0.000309	0.00127	CcSEcCtD
Bortezomib—Confusional state—Omeprazole—Barrett's esophagus	0.000309	0.00127	CcSEcCtD
Bortezomib—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.000307	0.00126	CcSEcCtD
Bortezomib—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.000307	0.00126	CcSEcCtD
Bortezomib—Infection—Esomeprazole—Barrett's esophagus	0.000305	0.00126	CcSEcCtD
Bortezomib—Infection—Omeprazole—Barrett's esophagus	0.000305	0.00126	CcSEcCtD
Bortezomib—Shock—Esomeprazole—Barrett's esophagus	0.000302	0.00124	CcSEcCtD
Bortezomib—Shock—Omeprazole—Barrett's esophagus	0.000302	0.00124	CcSEcCtD
Bortezomib—Nervous system disorder—Omeprazole—Barrett's esophagus	0.000301	0.00124	CcSEcCtD
Bortezomib—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.000301	0.00124	CcSEcCtD
Bortezomib—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.0003	0.00124	CcSEcCtD
Bortezomib—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.0003	0.00124	CcSEcCtD
Bortezomib—Tachycardia—Omeprazole—Barrett's esophagus	0.000299	0.00123	CcSEcCtD
Bortezomib—Tachycardia—Esomeprazole—Barrett's esophagus	0.000299	0.00123	CcSEcCtD
Bortezomib—Skin disorder—Omeprazole—Barrett's esophagus	0.000298	0.00123	CcSEcCtD
Bortezomib—Skin disorder—Esomeprazole—Barrett's esophagus	0.000298	0.00123	CcSEcCtD
Bortezomib—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.000296	0.00122	CcSEcCtD
Bortezomib—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.000296	0.00122	CcSEcCtD
Bortezomib—Anorexia—Esomeprazole—Barrett's esophagus	0.000292	0.0012	CcSEcCtD
Bortezomib—Anorexia—Omeprazole—Barrett's esophagus	0.000292	0.0012	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000279	0.00115	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000279	0.00115	CcSEcCtD
Bortezomib—Insomnia—Esomeprazole—Barrett's esophagus	0.000277	0.00114	CcSEcCtD
Bortezomib—Insomnia—Omeprazole—Barrett's esophagus	0.000277	0.00114	CcSEcCtD
Bortezomib—Paraesthesia—Esomeprazole—Barrett's esophagus	0.000275	0.00114	CcSEcCtD
Bortezomib—Paraesthesia—Omeprazole—Barrett's esophagus	0.000275	0.00114	CcSEcCtD
Bortezomib—Dyspnoea—Omeprazole—Barrett's esophagus	0.000273	0.00113	CcSEcCtD
Bortezomib—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000273	0.00113	CcSEcCtD
Bortezomib—Dyspepsia—Esomeprazole—Barrett's esophagus	0.00027	0.00111	CcSEcCtD
Bortezomib—Dyspepsia—Omeprazole—Barrett's esophagus	0.00027	0.00111	CcSEcCtD
Bortezomib—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000266	0.0011	CcSEcCtD
Bortezomib—Decreased appetite—Omeprazole—Barrett's esophagus	0.000266	0.0011	CcSEcCtD
Bortezomib—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000265	0.00109	CcSEcCtD
Bortezomib—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000265	0.00109	CcSEcCtD
Bortezomib—Fatigue—Omeprazole—Barrett's esophagus	0.000264	0.00109	CcSEcCtD
Bortezomib—Fatigue—Esomeprazole—Barrett's esophagus	0.000264	0.00109	CcSEcCtD
Bortezomib—Pain—Omeprazole—Barrett's esophagus	0.000262	0.00108	CcSEcCtD
Bortezomib—Constipation—Omeprazole—Barrett's esophagus	0.000262	0.00108	CcSEcCtD
Bortezomib—Pain—Esomeprazole—Barrett's esophagus	0.000262	0.00108	CcSEcCtD
Bortezomib—Constipation—Esomeprazole—Barrett's esophagus	0.000262	0.00108	CcSEcCtD
Bortezomib—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000253	0.00104	CcSEcCtD
Bortezomib—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000253	0.00104	CcSEcCtD
Bortezomib—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000251	0.00103	CcSEcCtD
Bortezomib—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000251	0.00103	CcSEcCtD
Bortezomib—Urticaria—Omeprazole—Barrett's esophagus	0.000244	0.001	CcSEcCtD
Bortezomib—Urticaria—Esomeprazole—Barrett's esophagus	0.000244	0.001	CcSEcCtD
Bortezomib—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000242	0.000999	CcSEcCtD
Bortezomib—Body temperature increased—Omeprazole—Barrett's esophagus	0.000242	0.000999	CcSEcCtD
Bortezomib—Abdominal pain—Omeprazole—Barrett's esophagus	0.000242	0.000999	CcSEcCtD
Bortezomib—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000242	0.000999	CcSEcCtD
Bortezomib—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000226	0.000931	CcSEcCtD
Bortezomib—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000226	0.000931	CcSEcCtD
Bortezomib—Asthenia—Esomeprazole—Barrett's esophagus	0.00022	0.000907	CcSEcCtD
Bortezomib—Asthenia—Omeprazole—Barrett's esophagus	0.00022	0.000907	CcSEcCtD
Bortezomib—Pruritus—Omeprazole—Barrett's esophagus	0.000217	0.000894	CcSEcCtD
Bortezomib—Pruritus—Esomeprazole—Barrett's esophagus	0.000217	0.000894	CcSEcCtD
Bortezomib—Diarrhoea—Esomeprazole—Barrett's esophagus	0.00021	0.000865	CcSEcCtD
Bortezomib—Diarrhoea—Omeprazole—Barrett's esophagus	0.00021	0.000865	CcSEcCtD
Bortezomib—Dizziness—Esomeprazole—Barrett's esophagus	0.000203	0.000836	CcSEcCtD
Bortezomib—Dizziness—Omeprazole—Barrett's esophagus	0.000203	0.000836	CcSEcCtD
Bortezomib—Vomiting—Esomeprazole—Barrett's esophagus	0.000195	0.000804	CcSEcCtD
Bortezomib—Vomiting—Omeprazole—Barrett's esophagus	0.000195	0.000804	CcSEcCtD
Bortezomib—Rash—Omeprazole—Barrett's esophagus	0.000193	0.000797	CcSEcCtD
Bortezomib—Rash—Esomeprazole—Barrett's esophagus	0.000193	0.000797	CcSEcCtD
Bortezomib—Dermatitis—Esomeprazole—Barrett's esophagus	0.000193	0.000796	CcSEcCtD
Bortezomib—Dermatitis—Omeprazole—Barrett's esophagus	0.000193	0.000796	CcSEcCtD
Bortezomib—Headache—Omeprazole—Barrett's esophagus	0.000192	0.000792	CcSEcCtD
Bortezomib—Headache—Esomeprazole—Barrett's esophagus	0.000192	0.000792	CcSEcCtD
Bortezomib—Nausea—Esomeprazole—Barrett's esophagus	0.000182	0.000751	CcSEcCtD
Bortezomib—Nausea—Omeprazole—Barrett's esophagus	0.000182	0.000751	CcSEcCtD
Bortezomib—PSMB8—RNF mutants show enhanced WNT signaling and proliferation—APC—Barrett's esophagus	0.000155	0.00204	CbGpPWpGaD
Bortezomib—PSMB8—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	0.000155	0.00204	CbGpPWpGaD
Bortezomib—CTSG—Metabolism of proteins—CXCL8—Barrett's esophagus	0.000154	0.00203	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000153	0.00201	CbGpPWpGaD
Bortezomib—CYP1A1—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000148	0.00195	CbGpPWpGaD
Bortezomib—PSMB1—Signaling by WNT in cancer—APC—Barrett's esophagus	0.000146	0.00193	CbGpPWpGaD
Bortezomib—PSMB2—Signaling by WNT in cancer—APC—Barrett's esophagus	0.000146	0.00193	CbGpPWpGaD
Bortezomib—PSMB5—Signaling by WNT in cancer—APC—Barrett's esophagus	0.000146	0.00193	CbGpPWpGaD
Bortezomib—PSMB8—Signaling by WNT in cancer—APC—Barrett's esophagus	0.000144	0.0019	CbGpPWpGaD
Bortezomib—PSMB5—B Cell Activation—RELA—Barrett's esophagus	0.000139	0.00183	CbGpPWpGaD
Bortezomib—PSMB2—B Cell Activation—RELA—Barrett's esophagus	0.000139	0.00183	CbGpPWpGaD
Bortezomib—PSMB1—B Cell Activation—RELA—Barrett's esophagus	0.000139	0.00183	CbGpPWpGaD
Bortezomib—PTGS1—Selenium Micronutrient Network—RELA—Barrett's esophagus	0.000137	0.00181	CbGpPWpGaD
Bortezomib—PSMB8—B Cell Activation—RELA—Barrett's esophagus	0.000137	0.0018	CbGpPWpGaD
Bortezomib—CYP2C8—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000135	0.00178	CbGpPWpGaD
Bortezomib—CYP1A2—Biological oxidations—CYP26A1—Barrett's esophagus	0.000135	0.00178	CbGpPWpGaD
Bortezomib—CYP1A2—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000133	0.00176	CbGpPWpGaD
Bortezomib—PTGS1—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	0.000133	0.00176	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—PTGES—Barrett's esophagus	0.00013	0.00171	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—PTGES—Barrett's esophagus	0.00013	0.00171	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—CYP26A1—Barrett's esophagus	0.00013	0.00171	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—PTGES—Barrett's esophagus	0.00013	0.00171	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—CYP26A1—Barrett's esophagus	0.000129	0.00171	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—CYP26A1—Barrett's esophagus	0.000129	0.0017	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—PTGES—Barrett's esophagus	0.000128	0.00169	CbGpPWpGaD
Bortezomib—PSMA1—Apoptosis—TP53—Barrett's esophagus	0.000127	0.00168	CbGpPWpGaD
Bortezomib—PSMB2—Gene Expression—NR1I2—Barrett's esophagus	0.000127	0.00167	CbGpPWpGaD
Bortezomib—PSMB5—Gene Expression—NR1I2—Barrett's esophagus	0.000127	0.00167	CbGpPWpGaD
Bortezomib—PSMB1—Gene Expression—NR1I2—Barrett's esophagus	0.000127	0.00167	CbGpPWpGaD
Bortezomib—PSMD1—Apoptosis—TP53—Barrett's esophagus	0.000127	0.00167	CbGpPWpGaD
Bortezomib—PSMD2—Apoptosis—TP53—Barrett's esophagus	0.000126	0.00166	CbGpPWpGaD
Bortezomib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000126	0.00166	CbGpPWpGaD
Bortezomib—PSMB8—Gene Expression—NR1I2—Barrett's esophagus	0.000125	0.00165	CbGpPWpGaD
Bortezomib—PSMB5—Cell Cycle Checkpoints—TP53—Barrett's esophagus	0.000121	0.00159	CbGpPWpGaD
Bortezomib—PSMB1—Cell Cycle Checkpoints—TP53—Barrett's esophagus	0.000121	0.00159	CbGpPWpGaD
Bortezomib—PSMB2—Cell Cycle Checkpoints—TP53—Barrett's esophagus	0.000121	0.00159	CbGpPWpGaD
Bortezomib—CYP2C19—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000121	0.00159	CbGpPWpGaD
Bortezomib—PSMB5—Signaling by Wnt—APC—Barrett's esophagus	0.00012	0.00159	CbGpPWpGaD
Bortezomib—PSMB2—Signaling by Wnt—APC—Barrett's esophagus	0.00012	0.00159	CbGpPWpGaD
Bortezomib—PSMB1—Signaling by Wnt—APC—Barrett's esophagus	0.00012	0.00159	CbGpPWpGaD
Bortezomib—PSMB8—Cell Cycle Checkpoints—TP53—Barrett's esophagus	0.000119	0.00157	CbGpPWpGaD
Bortezomib—PSMB8—Signaling by Wnt—APC—Barrett's esophagus	0.000119	0.00157	CbGpPWpGaD
Bortezomib—PSMA1—Disease—SLC9A1—Barrett's esophagus	0.000112	0.00148	CbGpPWpGaD
Bortezomib—PSMD1—Disease—SLC9A1—Barrett's esophagus	0.000111	0.00147	CbGpPWpGaD
Bortezomib—PSMD2—Disease—SLC9A1—Barrett's esophagus	0.000111	0.00146	CbGpPWpGaD
Bortezomib—CYP2C9—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.00011	0.00145	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000108	0.00142	CbGpPWpGaD
Bortezomib—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	0.000104	0.00138	CbGpPWpGaD
Bortezomib—CYP1A2—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	0.000104	0.00136	CbGpPWpGaD
Bortezomib—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000103	0.00136	CbGpPWpGaD
Bortezomib—PSMB8—Cytokine Signaling in Immune system—RELA—Barrett's esophagus	0.000102	0.00135	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—GAST—Barrett's esophagus	0.000102	0.00135	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—GAST—Barrett's esophagus	0.000102	0.00134	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—GAST—Barrett's esophagus	0.000101	0.00133	CbGpPWpGaD
Bortezomib—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	0.000101	0.00133	CbGpPWpGaD
Bortezomib—CYP1A1—PPARA activates gene expression—PPARG—Barrett's esophagus	9.98e-05	0.00132	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	9.86e-05	0.0013	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—CYP26A1—Barrett's esophagus	9.85e-05	0.0013	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—CYP26A1—Barrett's esophagus	9.85e-05	0.0013	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—CYP26A1—Barrett's esophagus	9.85e-05	0.0013	CbGpPWpGaD
Bortezomib—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—Barrett's esophagus	9.77e-05	0.00129	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—CYP26A1—Barrett's esophagus	9.71e-05	0.00128	CbGpPWpGaD
Bortezomib—PSMB2—Apoptosis—TP53—Barrett's esophagus	9.65e-05	0.00127	CbGpPWpGaD
Bortezomib—PSMB1—Apoptosis—TP53—Barrett's esophagus	9.65e-05	0.00127	CbGpPWpGaD
Bortezomib—PSMB5—Apoptosis—TP53—Barrett's esophagus	9.65e-05	0.00127	CbGpPWpGaD
Bortezomib—PSMB8—Apoptosis—TP53—Barrett's esophagus	9.51e-05	0.00125	CbGpPWpGaD
Bortezomib—CYP1A2—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	9.41e-05	0.00124	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—SLC9A1—Barrett's esophagus	9.37e-05	0.00124	CbGpPWpGaD
Bortezomib—PSMA1—Cell Cycle, Mitotic—CDKN2A—Barrett's esophagus	9.37e-05	0.00124	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—SLC9A1—Barrett's esophagus	9.33e-05	0.00123	CbGpPWpGaD
Bortezomib—PSMD1—Cell Cycle, Mitotic—CDKN2A—Barrett's esophagus	9.32e-05	0.00123	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—SLC9A1—Barrett's esophagus	9.28e-05	0.00122	CbGpPWpGaD
Bortezomib—PSMD2—Cell Cycle, Mitotic—CDKN2A—Barrett's esophagus	9.28e-05	0.00122	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	8.8e-05	0.00116	CbGpPWpGaD
Bortezomib—PSMB2—Disease—SLC9A1—Barrett's esophagus	8.48e-05	0.00112	CbGpPWpGaD
Bortezomib—PSMB1—Disease—SLC9A1—Barrett's esophagus	8.48e-05	0.00112	CbGpPWpGaD
Bortezomib—PSMB5—Disease—SLC9A1—Barrett's esophagus	8.48e-05	0.00112	CbGpPWpGaD
Bortezomib—PSMA1—Cell Cycle—CDKN2A—Barrett's esophagus	8.38e-05	0.0011	CbGpPWpGaD
Bortezomib—PSMB8—Disease—SLC9A1—Barrett's esophagus	8.36e-05	0.0011	CbGpPWpGaD
Bortezomib—PSMD1—Cell Cycle—CDKN2A—Barrett's esophagus	8.34e-05	0.0011	CbGpPWpGaD
Bortezomib—PSMD2—Cell Cycle—CDKN2A—Barrett's esophagus	8.3e-05	0.00109	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	8.02e-05	0.00106	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—GAST—Barrett's esophagus	7.74e-05	0.00102	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—GAST—Barrett's esophagus	7.74e-05	0.00102	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—GAST—Barrett's esophagus	7.74e-05	0.00102	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—HGF—Barrett's esophagus	7.72e-05	0.00102	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—HGF—Barrett's esophagus	7.68e-05	0.00101	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—HGF—Barrett's esophagus	7.65e-05	0.00101	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—GAST—Barrett's esophagus	7.64e-05	0.00101	CbGpPWpGaD
Bortezomib—PSMA1—Adaptive Immune System—RELA—Barrett's esophagus	7.38e-05	0.000974	CbGpPWpGaD
Bortezomib—PSMD1—Adaptive Immune System—RELA—Barrett's esophagus	7.35e-05	0.000969	CbGpPWpGaD
Bortezomib—PSMD2—Adaptive Immune System—RELA—Barrett's esophagus	7.31e-05	0.000964	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—SLC9A1—Barrett's esophagus	7.1e-05	0.000936	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—SLC9A1—Barrett's esophagus	7.1e-05	0.000936	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—SLC9A1—Barrett's esophagus	7.1e-05	0.000936	CbGpPWpGaD
Bortezomib—PSMB2—Cell Cycle, Mitotic—CDKN2A—Barrett's esophagus	7.1e-05	0.000936	CbGpPWpGaD
Bortezomib—PSMB5—Cell Cycle, Mitotic—CDKN2A—Barrett's esophagus	7.1e-05	0.000936	CbGpPWpGaD
Bortezomib—PSMB1—Cell Cycle, Mitotic—CDKN2A—Barrett's esophagus	7.1e-05	0.000936	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—SST—Barrett's esophagus	7e-05	0.000924	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—SLC9A1—Barrett's esophagus	7e-05	0.000923	CbGpPWpGaD
Bortezomib—PSMB8—Cell Cycle, Mitotic—CDKN2A—Barrett's esophagus	7e-05	0.000923	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—SST—Barrett's esophagus	6.97e-05	0.000919	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—SST—Barrett's esophagus	6.94e-05	0.000915	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	6.85e-05	0.000904	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—PTGES—Barrett's esophagus	6.8e-05	0.000896	CbGpPWpGaD
Bortezomib—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Barrett's esophagus	6.73e-05	0.000888	CbGpPWpGaD
Bortezomib—PSMB1—Cell Cycle—CDKN2A—Barrett's esophagus	6.35e-05	0.000837	CbGpPWpGaD
Bortezomib—PSMB2—Cell Cycle—CDKN2A—Barrett's esophagus	6.35e-05	0.000837	CbGpPWpGaD
Bortezomib—PSMB5—Cell Cycle—CDKN2A—Barrett's esophagus	6.35e-05	0.000837	CbGpPWpGaD
Bortezomib—PSMB8—Cell Cycle—CDKN2A—Barrett's esophagus	6.26e-05	0.000825	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—HGF—Barrett's esophagus	5.85e-05	0.000771	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—HGF—Barrett's esophagus	5.85e-05	0.000771	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—HGF—Barrett's esophagus	5.85e-05	0.000771	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—HGF—Barrett's esophagus	5.77e-05	0.00076	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—RELA—Barrett's esophagus	5.6e-05	0.000738	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—RELA—Barrett's esophagus	5.6e-05	0.000738	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—RELA—Barrett's esophagus	5.6e-05	0.000738	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—RELA—Barrett's esophagus	5.52e-05	0.000727	CbGpPWpGaD
Bortezomib—PSMA1—Gene Expression—PPARG—Barrett's esophagus	5.5e-05	0.000725	CbGpPWpGaD
Bortezomib—PSMD1—Gene Expression—PPARG—Barrett's esophagus	5.47e-05	0.000722	CbGpPWpGaD
Bortezomib—PSMD2—Gene Expression—PPARG—Barrett's esophagus	5.45e-05	0.000718	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—SST—Barrett's esophagus	5.31e-05	0.0007	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—SST—Barrett's esophagus	5.31e-05	0.0007	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—SST—Barrett's esophagus	5.31e-05	0.0007	CbGpPWpGaD
Bortezomib—PSMA1—Disease—APC—Barrett's esophagus	5.29e-05	0.000698	CbGpPWpGaD
Bortezomib—PSMD1—Disease—APC—Barrett's esophagus	5.27e-05	0.000694	CbGpPWpGaD
Bortezomib—PSMD2—Disease—APC—Barrett's esophagus	5.24e-05	0.000691	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—SST—Barrett's esophagus	5.23e-05	0.00069	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—CYP26A1—Barrett's esophagus	5.15e-05	0.000679	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PTGES—Barrett's esophagus	4.79e-05	0.000631	CbGpPWpGaD
Bortezomib—PSMA1—Cell Cycle—TP53—Barrett's esophagus	4.66e-05	0.000615	CbGpPWpGaD
Bortezomib—PSMD1—Cell Cycle—TP53—Barrett's esophagus	4.64e-05	0.000612	CbGpPWpGaD
Bortezomib—PSMD2—Cell Cycle—TP53—Barrett's esophagus	4.62e-05	0.000609	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—RELA—Barrett's esophagus	4.48e-05	0.000591	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—RELA—Barrett's esophagus	4.46e-05	0.000588	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—RELA—Barrett's esophagus	4.44e-05	0.000585	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PTGES—Barrett's esophagus	4.39e-05	0.000579	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—PPARG—Barrett's esophagus	4.28e-05	0.000564	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—PPARG—Barrett's esophagus	4.26e-05	0.000561	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—PPARG—Barrett's esophagus	4.24e-05	0.000559	CbGpPWpGaD
Bortezomib—PSMB2—Gene Expression—PPARG—Barrett's esophagus	4.17e-05	0.00055	CbGpPWpGaD
Bortezomib—PSMB5—Gene Expression—PPARG—Barrett's esophagus	4.17e-05	0.00055	CbGpPWpGaD
Bortezomib—PSMB1—Gene Expression—PPARG—Barrett's esophagus	4.17e-05	0.00055	CbGpPWpGaD
Bortezomib—PSMB8—Gene Expression—PPARG—Barrett's esophagus	4.11e-05	0.000542	CbGpPWpGaD
Bortezomib—PSMA1—Disease—PTGS2—Barrett's esophagus	4.02e-05	0.00053	CbGpPWpGaD
Bortezomib—PSMB5—Disease—APC—Barrett's esophagus	4.01e-05	0.000529	CbGpPWpGaD
Bortezomib—PSMB1—Disease—APC—Barrett's esophagus	4.01e-05	0.000529	CbGpPWpGaD
Bortezomib—PSMB2—Disease—APC—Barrett's esophagus	4.01e-05	0.000529	CbGpPWpGaD
Bortezomib—PSMD1—Disease—PTGS2—Barrett's esophagus	4e-05	0.000527	CbGpPWpGaD
Bortezomib—PSMD2—Disease—PTGS2—Barrett's esophagus	3.98e-05	0.000525	CbGpPWpGaD
Bortezomib—PSMB8—Disease—APC—Barrett's esophagus	3.95e-05	0.000521	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PTGES—Barrett's esophagus	3.92e-05	0.000517	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	3.81e-05	0.000502	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—SLC9A1—Barrett's esophagus	3.71e-05	0.00049	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—APC—Barrett's esophagus	3.71e-05	0.000489	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—APC—Barrett's esophagus	3.69e-05	0.000486	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—APC—Barrett's esophagus	3.67e-05	0.000484	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—CYP26A1—Barrett's esophagus	3.63e-05	0.000478	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PTGES—Barrett's esophagus	3.6e-05	0.000475	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PTGES—Barrett's esophagus	3.57e-05	0.000471	CbGpPWpGaD
Bortezomib—PSMB5—Cell Cycle—TP53—Barrett's esophagus	3.53e-05	0.000466	CbGpPWpGaD
Bortezomib—PSMB1—Cell Cycle—TP53—Barrett's esophagus	3.53e-05	0.000466	CbGpPWpGaD
Bortezomib—PSMB2—Cell Cycle—TP53—Barrett's esophagus	3.53e-05	0.000466	CbGpPWpGaD
Bortezomib—PSMB8—Cell Cycle—TP53—Barrett's esophagus	3.48e-05	0.000459	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—RELA—Barrett's esophagus	3.39e-05	0.000448	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—RELA—Barrett's esophagus	3.39e-05	0.000448	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—RELA—Barrett's esophagus	3.39e-05	0.000448	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—PTGS2—Barrett's esophagus	3.36e-05	0.000444	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—PTGS2—Barrett's esophagus	3.35e-05	0.000442	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—RELA—Barrett's esophagus	3.35e-05	0.000441	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—PTGS2—Barrett's esophagus	3.33e-05	0.000439	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—CYP26A1—Barrett's esophagus	3.33e-05	0.000439	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—PPARG—Barrett's esophagus	3.24e-05	0.000427	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—PPARG—Barrett's esophagus	3.24e-05	0.000427	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—PPARG—Barrett's esophagus	3.24e-05	0.000427	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—PPARG—Barrett's esophagus	3.2e-05	0.000421	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PTGES—Barrett's esophagus	3.05e-05	0.000403	CbGpPWpGaD
Bortezomib—PSMB2—Disease—PTGS2—Barrett's esophagus	3.04e-05	0.000401	CbGpPWpGaD
Bortezomib—PSMB5—Disease—PTGS2—Barrett's esophagus	3.04e-05	0.000401	CbGpPWpGaD
Bortezomib—PSMB1—Disease—PTGS2—Barrett's esophagus	3.04e-05	0.000401	CbGpPWpGaD
Bortezomib—PSMB8—Disease—PTGS2—Barrett's esophagus	3e-05	0.000396	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2.99e-05	0.000395	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—CYP26A1—Barrett's esophagus	2.97e-05	0.000392	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—RELA—Barrett's esophagus	2.9e-05	0.000382	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—RELA—Barrett's esophagus	2.88e-05	0.00038	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—RELA—Barrett's esophagus	2.87e-05	0.000378	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—APC—Barrett's esophagus	2.81e-05	0.00037	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—APC—Barrett's esophagus	2.81e-05	0.00037	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—APC—Barrett's esophagus	2.81e-05	0.00037	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—APC—Barrett's esophagus	2.77e-05	0.000365	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	2.73e-05	0.00036	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—CXCL8—Barrett's esophagus	2.73e-05	0.00036	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—CXCL8—Barrett's esophagus	2.72e-05	0.000358	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—CYP26A1—Barrett's esophagus	2.71e-05	0.000357	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—CXCL8—Barrett's esophagus	2.7e-05	0.000356	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.68e-05	0.000354	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—SLC9A1—Barrett's esophagus	2.62e-05	0.000345	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—PTGS2—Barrett's esophagus	2.55e-05	0.000336	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—PTGS2—Barrett's esophagus	2.55e-05	0.000336	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—PTGS2—Barrett's esophagus	2.55e-05	0.000336	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—PTGS2—Barrett's esophagus	2.51e-05	0.000331	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.46e-05	0.000324	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—SLC9A1—Barrett's esophagus	2.4e-05	0.000316	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PTGES—Barrett's esophagus	2.36e-05	0.000311	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CYP26A1—Barrett's esophagus	2.31e-05	0.000305	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—RELA—Barrett's esophagus	2.19e-05	0.000289	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—RELA—Barrett's esophagus	2.19e-05	0.000289	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—RELA—Barrett's esophagus	2.19e-05	0.000289	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.19e-05	0.000289	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—RELA—Barrett's esophagus	2.16e-05	0.000285	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—SLC9A1—Barrett's esophagus	2.14e-05	0.000282	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2.11e-05	0.000278	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—CXCL8—Barrett's esophagus	2.07e-05	0.000273	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—CXCL8—Barrett's esophagus	2.07e-05	0.000273	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—CXCL8—Barrett's esophagus	2.07e-05	0.000273	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—CXCL8—Barrett's esophagus	2.04e-05	0.000269	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2e-05	0.000264	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	1.97e-05	0.00026	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—SLC9A1—Barrett's esophagus	1.95e-05	0.000257	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.93e-05	0.000255	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	1.79e-05	0.000235	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.73e-05	0.000228	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.71e-05	0.000225	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—PPARG—Barrett's esophagus	1.69e-05	0.000223	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—TP53—Barrett's esophagus	1.67e-05	0.000221	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—SLC9A1—Barrett's esophagus	1.67e-05	0.00022	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—TP53—Barrett's esophagus	1.67e-05	0.00022	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—TP53—Barrett's esophagus	1.66e-05	0.000219	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.57e-05	0.000207	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.34e-05	0.000177	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—PTGS2—Barrett's esophagus	1.33e-05	0.000176	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	1.29e-05	0.00017	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—TP53—Barrett's esophagus	1.27e-05	0.000167	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—TP53—Barrett's esophagus	1.27e-05	0.000167	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—TP53—Barrett's esophagus	1.27e-05	0.000167	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—TP53—Barrett's esophagus	1.25e-05	0.000165	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PPARG—Barrett's esophagus	1.19e-05	0.000157	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PPARG—Barrett's esophagus	1.09e-05	0.000144	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PPARG—Barrett's esophagus	9.77e-06	0.000129	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PTGS2—Barrett's esophagus	9.39e-06	0.000124	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PPARG—Barrett's esophagus	8.99e-06	0.000118	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PPARG—Barrett's esophagus	8.91e-06	0.000117	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PTGS2—Barrett's esophagus	8.61e-06	0.000114	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PTGS2—Barrett's esophagus	7.69e-06	0.000101	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PPARG—Barrett's esophagus	7.61e-06	0.0001	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	7.07e-06	9.32e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PTGS2—Barrett's esophagus	7.01e-06	9.24e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PTGS2—Barrett's esophagus	5.99e-06	7.9e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PPARG—Barrett's esophagus	5.88e-06	7.75e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	4.62e-06	6.09e-05	CbGpPWpGaD
